Angiotensin Receptor Blockers for the Prevention of Atrial Fibrillation Recurrences: Unending Hot Debate.
作者信息
Celik Turgay
机构信息
Associate Professor of Cardiology, Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik-Ankara, Turkey.
出版信息
J Atr Fibrillation. 2010 Oct 22;3(3):306. doi: 10.4022/jafib.306. eCollection 2010 Oct-Nov.
Abstract
摘要
相似文献
1
Angiotensin Receptor Blockers for the Prevention of Atrial Fibrillation Recurrences: Unending Hot Debate.
J Atr Fibrillation. 2010 Oct 22;3(3):306. doi: 10.4022/jafib.306. eCollection 2010 Oct-Nov.
2
[Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
G Ital Cardiol (Rome). 2010 Nov;11(11):829-34.
3
Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
Minerva Cardioangiol. 2007 Jun;55(3):311-5.
4
Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Pharmacotherapy. 2009 Jan;29(1):31-48. doi: 10.1592/phco.29.1.31.
5
Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope.
Cardiovasc Drugs Ther. 2012 Feb;26(1):47-54. doi: 10.1007/s10557-011-6346-0.
6
Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence.
J Cardiovasc Med (Hagerstown). 2006 Jan;7(1):29-38. doi: 10.2459/01.JCM.0000199778.85343.08.
7
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation.
Curr Cardiol Rep. 2006 Sep;8(5):356-64. doi: 10.1007/s11886-006-0075-1.
8
Angiotensin II receptor blockers in the prevention of atrial fibrillation.
Expert Opin Pharmacother. 2009 Jun;10(9):1395-411. doi: 10.1517/14656560902973736.
9
The Role Of Renin Angiotensin System In Atrial Fibrillation.
J Atr Fibrillation. 2014 Apr 30;6(6):972. doi: 10.4022/jafib.972. eCollection 2014 Apr-May.
10
Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
Ann Intern Med. 2010 Jan 19;152(2):78-84. doi: 10.7326/0003-4819-152-2-201001190-00005.
引用本文的文献
1
Sodium-Glucose Co-Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
J Am Heart Assoc. 2021 Sep 7;10(17):e022222. doi: 10.1161/JAHA.121.022222. Epub 2021 Aug 28.
本文引用的文献
1
Effect of High-dose Telmisartan on the Prevention of Recurrent Atrial Fibrillation in Hypertensive Patients.
J Atr Fibrillation. 2010 Oct 22;3(3):289. doi: 10.4022/jafib.289. eCollection 2010 Oct-Nov.
2
Valsartan for prevention of recurrent atrial fibrillation.
N Engl J Med. 2009 Apr 16;360(16):1606-17. doi: 10.1056/NEJMoa0805710.
3
Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.
J Am Coll Cardiol. 2009 Jan 6;53(1):24-9. doi: 10.1016/j.jacc.2008.08.071.
4
Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
5
Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence.
Eur Heart J. 2006 Mar;27(5):512-8. doi: 10.1093/eurheartj/ehi668. Epub 2005 Nov 25.
6
The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: a randomized clinical study.
Clin Cardiol. 2005 Jun;28(6):298-302. doi: 10.1002/clc.4960280609.
7
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9. doi: 10.1016/j.jacc.2004.11.070.
8
Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
Int J Clin Pharmacol Res. 2005;25(1):41-6.
9
Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease.
Diabetes Care. 2004 Apr;27(4):1015. doi: 10.2337/diacare.27.4.1015.
10
Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans.
Circulation. 2000 Jun 13;101(23):2678-81. doi: 10.1161/01.cir.101.23.2678.
Zotero 插件